TL;DR: The Centers for Medicare & Medicaid Services modified NCD 71 governing pediatric liver transplantation coverage, effective January 9, 2026. Here's what billing teams at pediatric transplant programs need to know.
CMS pediatric liver transplantation coverage policy under NCD 71 sets the rules for which children qualify for Medicare-covered liver transplants and which hospitals can bill for the procedure. This update is a modification to the existing National Coverage Determination — not a new policy — but the criteria it codifies carry serious financial and operational weight for any pediatric transplant program. The policy does not list specific CPT or HCPCS codes, so your billing team will need to confirm correct procedure code assignment with your coding staff.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Pediatric Liver Transplantation |
| Policy Code | NCD 71 |
| Change Type | Modified |
| Effective Date | January 9, 2026 |
| Impact Level | High |
| Specialties Affected | Pediatric surgery, pediatric hepatology, transplant programs, inpatient hospital billing |
| Key Action | Verify your hospital's CMS-approved transplant program status and confirm your joint-program documentation is current before billing any pediatric liver transplant claims |
CMS Pediatric Liver Transplantation Coverage Criteria and Medical Necessity Requirements 2026
The core question in pediatric liver transplant billing is whether both the patient and the facility meet medical necessity and institutional criteria. Under NCD 71, CMS covers liver transplantation for children under 18 with extrahepatic biliary atresia or any other form of end-stage liver disease. Both diagnoses qualify — but not unconditionally.
Coverage is only available when a CMS-approved pediatric hospital performs the transplant. That hospital must have submitted an application to CMS documenting it meets specific institutional requirements. This is not a soft requirement. If your hospital has not received CMS approval, the claim will not be covered — full stop.
The medical necessity bar is set at end-stage liver disease. That language matters for documentation. Your clinical team needs to clearly establish the diagnosis in the medical record before the claim goes out. Extrahepatic biliary atresia is the most common qualifying diagnosis in pediatric cases, but any end-stage liver disease qualifies — provided the exclusions below don't apply.
Prior authorization requirements are not explicitly called out in this NCD, but that doesn't mean your MAC won't have additional local requirements. Check with your Medicare Administrative Contractor before assuming prior auth is not required for your region. Regional billing guidelines from your MAC can add layers that this NCD doesn't address.
The CMS pediatric liver transplantation coverage policy under NCD 71 is classified under two benefit categories: Inpatient Hospital Services and Physicians' Services. That means both the facility and the professional billing sides are in scope. Make sure your billing team is coordinating across both.
CMS Pediatric Liver Transplantation Exclusions and Non-Covered Indications
Two explicit exclusions apply under this coverage policy. Know them. They are not ambiguous.
Malignancy extending beyond the liver margins. If a child presents with a malignancy that has spread beyond the margins of the liver, CMS does not cover the transplant. This is a hard stop. Your documentation needs to confirm tumor staging and margin status before submission. A claim denial here isn't a documentation error — it's a coverage wall.
Persistent viremia. Children with persistent viremia are excluded from coverage. The clinical team must document viral status clearly. If viremia is present and persistent at the time of transplant, reimbursement is not available under NCD 71.
These two exclusions are worth building into your pre-authorization workflow, even where prior auth isn't formally required. If you can catch these contraindications on the front end, you avoid the downstream denial and the appeals burden. Talk to your compliance officer about adding a viremia and malignancy staging checkpoint to your transplant billing intake process.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Extrahepatic biliary atresia (patient under 18) | Covered | Not specified in NCD | Hospital must have CMS-approved pediatric transplant program |
| End-stage liver disease, other forms (patient under 18) | Covered | Not specified in NCD | Same institutional approval requirements apply |
| Malignancy extending beyond liver margins | Not Covered | Not specified in NCD | Hard exclusion — no coverage regardless of other criteria |
| Persistent viremia | Not Covered | Not specified in NCD | Hard exclusion — document viral status in medical record |
| Pediatric liver transplant at non-approved facility | Not Covered | Not specified in NCD | Facility must have CMS-approved program; joint-program requirements apply |
CMS Pediatric Liver Transplantation Billing Guidelines and Action Items 2026
These are concrete steps your billing team should take in response to the January 9, 2026 effective date.
| # | Action Item |
|---|---|
| 1 | Confirm your hospital's CMS approval status now. If your pediatric hospital performs liver transplants and bills Medicare, verify that your CMS application was approved and that the approval is current. If you're not sure of your status, check with your compliance officer before the next transplant claim goes out. An unapproved facility cannot bill for these services under NCD 71. |
| 2 | Audit your joint-program documentation. NCD 71 requires that a qualifying pediatric liver transplant program operate jointly with another CMS-approved facility. That joint program must share the same transplant surgeons and the same quality assurance infrastructure — including the oversight committee, patient protocol, and patient selection criteria. If your QA program documentation hasn't been reviewed recently, do it now. |
| 3 | Build exclusion checks into your pre-billing workflow. Add explicit screening for malignancy margin status and persistent viremia to your transplant billing intake. Both are hard exclusions under this coverage policy. A claim denied on either ground is not appealable on medical necessity grounds — the policy simply doesn't cover those cases. |
| 4 | Coordinate inpatient and professional billing. NCD 71 covers services under both Inpatient Hospital Services and Physicians' Services. Make sure your facility billing team and your physician billing team are aligned on the same coverage criteria and exclusions. Gaps between the two create inconsistent documentation and increase claim denial risk. |
| 5 | Check with your MAC for local coverage determinations. NCD 71 is a national policy, but your Medicare Administrative Contractor may have issued an LCD or billing guidelines that add regional requirements. Contact your MAC to confirm there are no additional prior authorization requirements or documentation standards that apply in your jurisdiction. |
| 6 | Document medical necessity explicitly in the medical record. The treating physician's notes need to establish end-stage liver disease clearly. "End-stage liver disease" should appear as a working diagnosis with supporting clinical evidence. Extrahepatic biliary atresia should be coded and documented with specificity. Loose documentation here is the easiest path to a denial. |
| 7 | Alert your coding team that NCD 71 does not list specific CPT or HCPCS codes. Your coders need to assign the correct procedure codes based on what was actually performed. Pediatric liver transplantation billing guidelines at the code level will depend on your coding team's reference materials and any MAC guidance. This is an area where a conversation with your billing consultant or coding director is worth the time. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Pediatric Liver Transplantation Under NCD 71
The Centers for Medicare & Medicaid Services did not list specific CPT, HCPCS, or ICD-10 codes in NCD 71. This is a meaningful gap for billing teams.
Your coding team will need to assign procedure codes based on the specific transplant services performed. For ICD-10-CM diagnosis coding, extrahepatic biliary atresia and end-stage liver disease each have specific codes — and selecting the right one matters for medical necessity review. Work with your coding director or a certified transplant coder to confirm the correct code assignments for each case.
Because this NCD does not enumerate codes, there is also no code-level exclusion table. The exclusions are clinical — malignancy beyond liver margins and persistent viremia — not code-specific. Document the underlying diagnosis accurately and the exclusion logic will follow.
If you're getting inconsistent results on transplant claims, the absence of code-level guidance in this NCD is likely part of the problem. Loop in your billing consultant to review your current code assignments against what your MAC expects.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.